Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

Projektinformationen

SQUEEZE

ID Finanzhilfevereinbarung: 101095052

DOI

10.3030/101095052

EK-Unterschriftsdatum 25 November 2022

Startdatum 1 Dezember 2022

Enddatum 30 November 2027

Finanziert unter

• Health

Gesamtkosten

€ 9 197 602,50

EU-Beitrag

€ 9 197 602,50

Koordiniert durch

MEDIZINISCHE UNIVERSITAET WIEN
Austria

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Documents, reports (11)

Descriptive map of TTV values
Ethics and Governance framework

Building the framework for ethics and governance

First submission package of RA-DRUM trial
Report on Associations between serum drug levels and anti-drug antibodies and clinical outcomes
Report on Data platform, warehousing and data & script sharing
Updated Plan on dissemination, exploitation and communication (DEC) of results

This deliverable gives an overview of the planned DEC activities for the project- including planned events and activities, and a first version of communication documents and templates- and a collection of PPTs that can be used as a basis for presentation of Squeeze. The PPTs and templates collected on the Squeeze online portal (for consortium only) will be updated as needed. The report includes website implementation in a first version (including public information/PPTs) and social media (current plan is focusing on LinkedIn and Twitter) initiated.

Risk assessment Report, study monitoring will be carried out throughout the trial with end of study report

First submission package BioBest Trial

Report on SQUEEZE stakeholder strategy
Conclusions from the Kick-off Meeting

Summary reporting of Kick-off meeting

First submission package of MethMax trial; reporting of MTX responder dynamics

First submission package of MethMax trial and reporting of MTX responder dynamics to inform trial

Report with contextual analysis - Map of practice patterns of RA care, use of precision medicine approaches

Websites, patent fillings, videos etc. (1)

public web site

Veröffentlichungen

Peer reviewed articles (4)

Time-independent disease state identification defines distinct trajectories determined by localised vs systemic inflammation in patients with early rheumatoid arthritis

Autoren: Nils Steinz, Tjardo D. Maarseveen, Erik B. van den Akker, Andrew P. Cope, John D. Isaacs, Aaron R. Winkler, Tom W. J. Huizinga, Yann Abraham, Rachel Knevel
Veröffentlicht in: Annals of the Rheumatic Diseases, Ausgabe 84, 2025, ISSN 0003-4967
Herausgeber: Elsevier BV
DOI: 10.1016/J.ARD.2025.04.011

Location and amount of joint involvement differentiates rheumatoid arthritis into different clinical subsets

Autoren: Tjardo D. Maarseveen; Marc P. Maurits; Lavinia Agra Coletto; Simone Perniola; Stefan Böhringer; Nils Steinz; Sytske Anne Bergstra; Dario Bruno; Maria Rita Gigante; Viviana A. Pacucci; Luca Petricca; Bianca Boxma-de Klerk; Herman Kasper Glas; Clara Di Mario; Denise Campobasso; Barbara Tolusso; Josien Veris-van Dieren; Annette H. M. Helm-van Mil; Elisa Gremese; Maria Antonietta D’Agostino; Marcel J T. Reinders; Marco Gessi; Tom W J Huizinga; Stefano Alivernini; Erik B. Akker; Rachel Knevel
Veröffentlicht in: npj Digital Medicine, 2025, ISSN 2398-6352
Herausgeber: Springer Nature
DOI: 10.1038/S41746-025-01997-1

Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline

Autoren: Kawano-Dourado, Leticia; Kristianslund, Eirik Klami; Zeraatkar, Dena; Jani, Meghna; Makharia, Govind; Hazlewood, Glen; Smith, Catherine; Jess, Tine; Stabell, Camilla; Schatten, Arne; Owen, Andrew; Gehin, Johanna; Katsidzira, Leolin; Weinberg, David; Bauer-Ventura, Iazsmin; Tugwell, Peter; Moayyedi, Paul; Cecchi, Ana Veronica Wolff; Shimabuco, Andrea; Seterelv, Siri; Gyuatt, Gordon; Agoritsas, Thomas; Vandvik, Per Olav
Veröffentlicht in: BMJ, 2024, ISSN 1756-1833
Herausgeber: BMJ Publishing Group Ltd
DOI: 10.1136/BMJ-2024-079830

Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial

Autoren: Johanna Elin Gehin; Rolf Anton Klaasen; Eirik Klami Kristianslund; Ingrid Jyssum; Joseph Sexton; David John Warren; Daniel Aletaha; Espen Andre Haavardsholm; Silje Watterdal Syversen; Guro Løvik Goll; Nils Bolstad
Veröffentlicht in: RMD Open, 2024, ISSN 2056-5933
Herausgeber: BMJ Publishing Group
DOI: 10.1136/RMDOPEN-2024-004888